2,3-Quinoxalinedione,1,4-dihydro-,monooxime(9CI)
Modify Date: 2025-09-19 13:02:13
2,3-Quinoxalinedione,1,4-dihydro-,monooxime(9CI) structure
|
Common Name | 2,3-Quinoxalinedione,1,4-dihydro-,monooxime(9CI) | ||
|---|---|---|---|---|
| CAS Number | 177944-77-3 | Molecular Weight | 177.16000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C8H7N3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 2-(hydroxymethylidene)-1,4-dihydropyrido[2,3-b]pyrazin-3-one |
|---|
| Molecular Formula | C8H7N3O2 |
|---|---|
| Molecular Weight | 177.16000 |
| Exact Mass | 177.05400 |
| PSA | 82.03000 |
| LogP | 0.24060 |
| InChIKey | PQOJIECBMCIOPW-UHFFFAOYSA-N |
| SMILES | O=c1[nH]c2ccccc2nc1NO |
|
~41%
2,3-Quinoxaline... CAS#:177944-77-3 |
| Literature: State of Oregon, Acting by and through the Oregon State Board of Higher Education, Acting for and on Behalf of the Oregon Health Sciences University and the University of Oregon; Acea Pharmaceuticals, Inc.; The Regents of the University of California Patent: US5597922 A1, 1997 ; US 5597922 A |
|
~0%
2,3-Quinoxaline... CAS#:177944-77-3 |
| Literature: State of Oregon, Acting by and through the Oregon State Board of Higher Education, Acting for and on Behalf of the Oregon Health Sciences University and the University of Oregon; Acea Pharmaceuticals, Inc.; The Regents of the University of California Patent: US5597922 A1, 1997 ; US 5597922 A |
